Showing results (91-100 of 268) with videos related to
Sort By:
Pageof 27
Journal of Bacteriology|August 28, 1999
Regulation of cell component production by growth rate in the group B StreptococcusR A Ross, L C Madoff, L C PaolettiCancer Research|October 1, 1986
Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cellsA K Larsen, J Paoletti, J Belehradek, et al.Biochemical Pharmacology|December 15, 1988
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugsS Orlowski, J Belehradek, C Paoletti, et al.European Journal of Cancer (Oxford, England : 1990)|January 11, 1991
Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulsesL M Mir, S Orlowski, J Belehradek, et al.Mutation Research|November 1, 1988
Frameshift mutagenesis in Escherichia coli by reversible DNA intercalators: sequence specificityB René, C Auclair, R P Fuchs, et al.Biology of the Cell|January 1, 1988
ATP-independent DNA topoisomerase II as potential drug target in trypanosomesS Douc-Rasy, J F Riou, J C Ahomadegbe, et al.Neoplasma|January 1, 1983
Soft agar clonogenic assay in human breast cancerJ Benard, P Schreiner, J C Delarue, et al.Oncogene Research|January 1, 1988
Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosisM Guérin, M Barrois, M J Terrier, et al.Pathologie-Biologie|November 1, 1987
[Study, at the gene level, of the activation of topoisomerase II by antitumor agents]M J Vilarem, J F Riou, G Riou, et al.Biochemical Pharmacology|December 15, 1986
Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene. In vitro stimulation by the antitumoral intercalating drug mAMSAJ F Riou, M J Vilarem, C J Larsen, et al.Pageof 27